Literature DB >> 17310141

Intraplantar PGE2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases.

C A L Kassuya1, J Ferreira, R F Claudino, J B Calixto.   

Abstract

BACKGROUND AND
PURPOSE: Receptor subtypes involved in PGE(2)-induced nociception are still controversial. The present study investigated the prostanoid E receptor (EP) subtypes and the protein kinase (PK) pathways involved in the nociception induced by PGE(2) injection in the mouse paw. EXPERIMENTAL APPROACH: Paw-licking and mechanical allodynia were measured in vivo and protein kinase activation ex vivo by Western blots of extracts of paw skin. KEY
RESULTS: Intraplantar (i.pl.) injection of PGE(2) into the mouse paw caused nociceptive behaviour of short duration with mean ED(50) of 1.43 nmol. PGE(2) produced a longer-lasting mechanical allodynia, with an ED(50) of 0.05 nmol. Intraplantar injection of antagonists at EP(3) or EP(4), but not at EP(1) or EP(2) receptors inhibited PGE(2)-induced paw-licking. Paw-licking caused by PGE(2) was blocked by an inhibitor of PKA but only partially decreased by inhibition of the extracellular-regulated kinase (ERK). Selective inhibitors of PKC, c-Jun N-terminal kinase (JNK) or p38, all failed to affect PGE(2)-induced paw-licking. An EP(3) antagonist inhibited PGE(2)-induced mechanical allodynia. However, inhibitors of PKA, PKC or ERK, but not p38 or JNK, also partially inhibited PGE(2)-induced mechanical allodynia. Western blot analyses confirmed that i.pl. injection of PGE(2) activated PKA, PKCalpha, and mitogen activated kinases (MAPKs) in the paw. Co-treatment with EP(3) or EP(4) receptor antagonists reduced PGE(2)-induced PKA and ERK, but not PKCalpha activation. CONCLUSIONS AND IMPLICATIONS: The present results indicate that the nociceptive behaviour and mechanical allodynia caused by i.pl. PGE(2) are mediated through activation of distinct EP receptors and PK-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310141      PMCID: PMC2013868          DOI: 10.1038/sj.bjp.0707149

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia.

Authors:  Y O Taiwo; J D Levine
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

2.  Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system.

Authors:  Y Sugimoto; R Shigemoto; T Namba; M Negishi; N Mizuno; S Narumiya; A Ichikawa
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

3.  Ethical guidelines for investigations of experimental pain in conscious animals.

Authors:  Manfred Zimmermann
Journal:  Pain       Date:  1983-06       Impact factor: 6.961

4.  Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw?

Authors:  S G Khasar; A K Ouseph; B Chou; T Ho; P G Green; J D Levine
Journal:  Neuroscience       Date:  1995-02       Impact factor: 3.590

5.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

6.  Behavioural effects of intraplantar injection of inflammatory mediators in the rat.

Authors:  Y Hong; F V Abbott
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

7.  Prostaglandin E2-induced sensitization of the heat response of canine visceral polymodal receptors in vitro.

Authors:  K Mizumura; M Minagawa; Y Tsujii; T Kumazawa
Journal:  Neurosci Lett       Date:  1993-10-14       Impact factor: 3.046

8.  Involvement of EP3 subtype of prostaglandin E receptors in PGE2-induced enhancement of the bradykinin response of nociceptors.

Authors:  T Kumazawa; K Mizumura; H Koda
Journal:  Brain Res       Date:  1993-12-31       Impact factor: 3.252

9.  Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2.

Authors:  S Mense
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

10.  Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2.

Authors:  H G Schaible; R F Schmidt
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

View more
  15 in total

1.  The lipid kinase PIP5K1C regulates pain signaling and sensitization.

Authors:  Brittany D Wright; Lipin Loo; Sarah E Street; Anqi Ma; Bonnie Taylor-Blake; Michael A Stashko; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

2.  Antihypernociceptive activity of anethole in experimental inflammatory pain.

Authors:  Alessandra M V Ritter; Talita P Domiciano; Waldiceu A Verri; Ana Carla Zarpelon; Lorena G da Silva; Carmem P Barbosa; Maria Raquel M Natali; Roberto K N Cuman; Ciomar A Bersani-Amado
Journal:  Inflammopharmacology       Date:  2012-10-09       Impact factor: 4.473

3.  The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats.

Authors:  J F Lima-Garcia; R C Dutra; Kabs da Silva; E M Motta; M M Campos; J B Calixto
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Molecular Roles of Cdk5 in Pain Signaling.

Authors:  Elias Utreras; Akira Futatsugi; Tej Kumar Pareek; Ashok B Kulkarni
Journal:  Drug Discov Today Ther Strateg       Date:  2009-09

5.  Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.

Authors:  J Günther; K Schulte; D Wenzel; B Malinowska; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

Review 6.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

7.  The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception.

Authors:  D Sachs; Cf Villarreal; Fq Cunha; Ca Parada; Sh Ferreira
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

8.  Aleurites moluccana (L.) Willd. Leaves: Mechanical Antinociceptive Properties of a Standardized Dried Extract and Its Chemical Markers.

Authors:  Nara L M Quintão; Christiane Meyre-Silva; Gislaine F Silva; Carla S Antonialli; Lilian W Rocha; Ruth M Lucinda-Silva; Angela Malheiros; Márcia M Souza; Valdir Cechinel Filho; Tania M B Bresolin
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-23       Impact factor: 2.629

9.  Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain.

Authors:  Yi-Ruu Lin; Hwei-Hsien Chen; Yu-Chin Lin; Chien-Hsin Ko; Ming-Huan Chan
Journal:  J Biomed Sci       Date:  2009-10-16       Impact factor: 8.410

10.  Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation.

Authors:  Branden A Smeester; Mona Al-Gizawiy; Alvin J Beitz
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.